Skip to main content
Year archive

Opthea Ltd — 2020 filings

All 100 regulatory filings released by Opthea Ltd (OPT) in 2020, sourced directly from the official regulator.

100 Filings
2020 Period
2020 filings (100)
Filing Released Lang
6-K
Foreign Filer Report
2020-12-17 English
Notice of General Meeting and Proxy Form 44 pages 958.1KB
Regulatory Filings
2020-12-16 English
Becoming a substantial holder 40 pages 722.9KB
Regulatory Filings
2020-12-16 English
Ceasing to be a substantial holder 18 pages 195.4KB
Regulatory Filings
2020-12-15 English
Change in substantial holding 5 pages 1.9MB
Regulatory Filings
2020-12-14 English
Change in substantial holding 20 pages 331.3KB
Regulatory Filings
2020-12-14 English
Becoming a substantial holder 40 pages 780.3KB
Regulatory Filings
2020-12-09 English
Ceasing to be a substantial holder 22 pages 305.5KB
Regulatory Filings
2020-12-06 English
S-8
Registration Form
2020-12-01 English
Change in substantial holding 5 pages 895.7KB
Regulatory Filings
2020-11-22 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-11-11 English
Change in substantial holding 19 pages 334.4KB
Regulatory Filings
2020-11-09 English
Change in substantial holding 5 pages 1.9MB
Regulatory Filings
2020-11-08 English
Change in substantial holding 19 pages 334.1KB
Regulatory Filings
2020-11-05 English
Change in substantial holding 5 pages 897.1KB
Regulatory Filings
2020-11-05 English
Change in substantial holding 5 pages 1.9MB
Regulatory Filings
2020-11-04 English
Change in substantial holding 5 pages 894.4KB
Regulatory Filings
2020-11-03 English
Change in substantial holding 19 pages 322.4KB
Regulatory Filings
2020-11-01 English
Change in substantial holding 5 pages 901.6KB
Regulatory Filings
2020-10-28 English
6-K
Foreign Filer Report
2020-10-27 English
Opthea Receives A$8.5m R&D Tax Incentive 2 pages 73.9KB
Regulatory Filings
2020-10-26 English
Becoming a substantial holder 47 pages 873.0KB
Regulatory Filings
2020-10-22 English
Final Director's Interest Notice - GK 2 pages 172.8KB
Regulatory Filings
2020-10-22 English
Becoming a substantial holder 73 pages 1.7MB
Regulatory Filings
2020-10-21 English
Change in substantial holding 17 pages 591.5KB
Regulatory Filings
2020-10-21 English
6-K
Foreign Filer Report
2020-10-21 English
Opthea Announces Closing of US Initial Public Offering 251 pages 3.2MB
Regulatory Filings
2020-10-20 English
Ceasing to be a substantial holder 10 pages 165.4KB
Regulatory Filings
2020-10-20 English
424B4
Prospectus
2020-10-19 English
Change in substantial holding 2 pages 129.5KB
Regulatory Filings
2020-10-19 English
Regulatory Filings 2020
Regulatory Filings
2020-10-19 English
Opthea Announces Pricing of US Initial Public Offering 2 pages 165.3KB
Regulatory Filings
2020-10-18 English
Proposed issue of Securities - OPT 7 pages 34.1KB
Regulatory Filings
2020-10-18 English
Appendix 2A 15 pages 222.6KB
Regulatory Filings
2020-10-18 English
Cleansing Notice 1 page 204.8KB
Regulatory Filings
2020-10-18 English
Regulatory Filings 2020
Regulatory Filings
2020-10-15 English
Regulatory Filings 2020
Regulatory Filings
2020-10-15 English
Regulatory Filings 2020
Regulatory Filings
2020-10-15 English
8A CERT
Regulatory Filings
2020-10-15 English
F-1/A
Regulatory Filings
2020-10-15 English
Trading Halt 2 pages 247.4KB
Regulatory Filings
2020-10-15 English
8-A12B
Regulatory Filings
2020-10-14 English
Becoming a substantial holder 61 pages 306.8KB
Regulatory Filings
2020-10-14 English
Initial Director's Interest Notice - JL 2 pages 134.2KB
Regulatory Filings
2020-10-14 English
Opthea Chairman Address to the 2020 Annual General Meeting 3 pages 177.9KB
Regulatory Filings
2020-10-11 English
Trading Halt 2 pages 246.8KB
Regulatory Filings
2020-10-11 English
Results of Meeting 2 pages 484.2KB
Regulatory Filings
2020-10-11 English
Opthea Launches Proposed US Initial Public Offering 2 pages 161.2KB
Regulatory Filings
2020-10-11 English
Regulatory Filings 2020
Regulatory Filings
2020-10-09 English
F-1/A
Regulatory Filings
2020-10-09 English
Regulatory Filings 2020
Regulatory Filings
2020-10-05 English
Opthea to Appoint Dr Jeremy Levin as Chairman of the Board 2 pages 109.8KB
Regulatory Filings
2020-10-04 English
Ceasing to be a substantial holder 10 pages 162.2KB
Regulatory Filings
2020-09-28 English
F-1
Regulatory Filings
2020-09-24 English
Opthea Files Registration Statement for Proposed US IPO 2 pages 162.1KB
Regulatory Filings
2020-09-24 English
Change in substantial holding 14 pages 64.1KB
Regulatory Filings
2020-09-22 English
Change in substantial holding 55 pages 252.2KB
Regulatory Filings
2020-09-21 English
Regulatory Filings 2020
Regulatory Filings
2020-09-16 English
Initial Director's Interest Notice - DS 2 pages 133.9KB
Regulatory Filings
2020-09-14 English
Annual Report 2020 72 pages 4.3MB
Regulatory Filings
2020-09-10 English
Appendix 4G and Corporate Governance Statement 2020 22 pages 541.8KB
Regulatory Filings
2020-09-10 English
Notice of Annual General Meeting and Proxy Form 54 pages 801.6KB
Regulatory Filings
2020-09-10 English
Opthea Appoints US-Based Non-Executive Director 2 pages 101.1KB
Regulatory Filings
2020-09-09 English
Regulatory Filings 2020
Regulatory Filings
2020-09-02 English
Regulatory Filings 2020
Regulatory Filings
2020-09-02 English
Opthea Full Year Financial Report 2020 56 pages 591.1KB
Regulatory Filings
2020-08-27 English
Opthea Announces Plans for Potential US listing and IPO 1
Regulatory Filings
2020-08-23 English
Opthea Completes Successful FDA and EMA Meetings for Phase 3 3 pages 105.6KB
Regulatory Filings
2020-08-20 English
Regulatory Filings 2020
Regulatory Filings
2020-08-14 English
Opthea Key Opinion Leader Symposium Presentation 61 pages 3.0MB
Regulatory Filings
2020-08-05 English
Opthea to Host Key Opinion Leader Symposium on wAMD and DME 2 pages 97.4KB
Regulatory Filings
2020-07-27 English
Opthea Presents New Data from Ph 1b/2a DME Trial at ASRS 4 pages 294.3KB
Regulatory Filings
2020-07-26 English
Corporate Presentation of Ph1b/2a DME Trial Data (ASRS) 25 pages 1.3MB
Regulatory Filings
2020-07-26 English
Initial Director's Interest Notice - LG 2 pages 150.9KB
Regulatory Filings
2020-07-26 English
Opthea Appoints New Non-Executive Director 2 pages 98.6KB
Regulatory Filings
2020-07-23 English
Opthea to Present OPT-302 DME Clinical Data at ASRS 2020 2 pages 123.8KB
Regulatory Filings
2020-07-22 English
Regulatory Filings 2020
Regulatory Filings
2020-07-17 English
Change in substantial holding 17 pages 76.2KB
Regulatory Filings
2020-06-25 English
Opthea Added to the S&P/ASX 300 Index 2 pages 88.2KB
Regulatory Filings
2020-06-21 English
Change in substantial holding 20 pages 444.4KB
Regulatory Filings
2020-06-21 English
Opthea Reports Positive Ph2a Trial Results of OPT-302 in DME 5 pages 247.8KB
Regulatory Filings
2020-06-09 English
Trading Halt 2 pages 247.6KB
Regulatory Filings
2020-06-08 English
Opthea to Host Investor Teleconference 3 pages 180.4KB
Regulatory Filings
2020-06-08 English
Change in substantial holding 2 pages 78.4KB
Regulatory Filings
2020-06-01 English
Change in substantial holding 21 pages 103.4KB
Regulatory Filings
2020-05-04 English
Change in substantial holding 2 pages 79.0KB
Regulatory Filings
2020-04-15 English
Becoming a substantial holder 51 pages 259.4KB
Regulatory Filings
2020-03-30 English
Opthea Completes Patient Dosing in Phase 2a DME Trial 3 pages 170.3KB
Regulatory Filings
2020-03-29 English
Ceasing to be a substantial holder from MS 16 pages 922.0KB
Regulatory Filings
2020-03-25 English
Ceasing to be a substantial holder from MUFG 12 pages 386.4KB
Regulatory Filings
2020-03-25 English
Becoming a substantial holder from MS 84 pages 5.0MB
Regulatory Filings
2020-03-23 English
Becoming a substantial holder from MUFG 111 pages 446.2KB
Regulatory Filings
2020-03-23 English
Change in substantial holding 3 pages 90.6KB
Regulatory Filings
2020-03-17 English
Ceasing to be a substantial holder 12 pages 171.4KB
Regulatory Filings
2020-03-17 English
Becoming a substantial holder 48 pages 766.3KB
Regulatory Filings
2020-03-12 English
Opthea Half Year Report and Accounts 24 pages 1.5MB
Regulatory Filings
2020-02-25 English
Opthea to Present at SVB Leerink Healthcare Conference 2 pages 65.5KB
Regulatory Filings
2020-02-16 English
Ceasing to be a substantial holder 11 pages 437.4KB
Regulatory Filings
2020-01-15 English
Becoming a substantial holder 32 pages 508.3KB
Regulatory Filings
2020-01-08 English
Opthea Completes Recruitment in Ph2a Trial of OPT-302 in DME 3 pages 74.4KB
Regulatory Filings
2020-01-06 English